Hepatocyte-Derived VEGFA Accelerates the Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma via Activating Hepatic Stellate Cells

LX2 cells could be activated by conditioned medium from NAFLD-derived organoids, but not from HBV livers, whereas this activation was blocked by a VEGFA antibody.